Interactions between microbiota and cervical epithelial, immune, and mucus barrier

Mengting Dong,Yalan Dong,Junyi Bai,Huanrong Li,Xiaotong Ma,Bijun Li,Chen Wang,Huiyang Li,Wenhui Qi,Yingmei Wang,Aiping Fan,Cha Han,Fengxia Xue
DOI: https://doi.org/10.3389/fcimb.2023.1124591
IF: 6.073
2023-02-25
Frontiers in Cellular and Infection Microbiology
Abstract:The female reproductive tract harbours hundreds of bacterial species and produces numerous metabolites. The uterine cervix is located between the upper and lower parts of the female genital tract. It allows sperm and birth passage and hinders the upward movement of microorganisms into a relatively sterile uterus. It is also the predicted site for sexually transmitted infection (STI), such as Chlamydia, human papilloma virus (HPV), and human immunodeficiency virus (HIV). The healthy cervicovaginal microbiota maintains cervical epithelial barrier integrity and modulates the mucosal immune system. Perturbations of the microbiota composition accompany changes in microbial metabolites that induce local inflammation, damage the cervical epithelial and immune barrier, and increase susceptibility to STI infection and relative disease progression. This review examined the intimate interactions between the cervicovaginal microbiota, relative metabolites, and the cervical epithelial-, immune-, and mucus barrier, and the potent effect of the host-microbiota interaction on specific STI infection. An improved understanding of cervicovaginal microbiota regulation on cervical microenvironment homeostasis might promote advances in diagnostic and therapeutic approaches for various STI diseases.
immunology,microbiology
What problem does this paper attempt to address?